Cargando…
Melanoma Risk is Increased in Patients with Mycosis Fungoides Compared with Patients with Psoriasis and the General Population
Patients with mycosis fungoides (MF) are thought to be at increased risk of melanoma. However, studies addressing surveillance-bias and treatments as a possible confounder are lacking. This retrospective study compared the prevalence and risk of melanoma between 982 patients with MF, and 3,165 patie...
Autores principales: | SHERMAN, Shany, KREMER, Noa, DALAL, Adam, SOLOMON-COHEN, Efrat, BERCOVICH, Einav, NOYMAN, Yehonatan, BEN-LASSAN, Maya, LEVI, Noa, PAVLOVSKY, Lev, PRAG NAVEH, Hadas, HODAK, Emmilia, AMITAY-LAISH, Iris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Publication of Acta Dermato-Venereologica
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309703/ https://www.ncbi.nlm.nih.gov/pubmed/33241425 http://dx.doi.org/10.2340/00015555-3704 |
Ejemplares similares
-
Ixekizumab Survival in Heavily Pretreated Patients with Psoriasis: A Two-year Single-centre Retrospective Study
por: SHERMAN, Shany, et al.
Publicado: (2020) -
Stage-dependent Increase in Expression of miR-155 and Ki-67 and Number of Tumour-associated Inflammatory Cells in Folliculotropic Mycosis Fungoides
por: ATZMONY, Lihi, et al.
Publicado: (2020) -
The Course of Mycosis Fungoides under Cytokine Pathway Blockers: A Multicentre Analysis of Real-life Clinical Data
por: AMITAY-LAISH, Iris, et al.
Publicado: (2020) -
The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin
por: Moyal, Lilach, et al.
Publicado: (2016) -
mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy
por: Knaneh, Jamal, et al.
Publicado: (2023)